Recombinant Human GM-CSF for Large-Scale Collection of Circulating Hematopoietic Progenitors in Cancer Patients Treated with High-Dose Cyclophosphamide
暂无分享,去创建一个
G. Bonadonna | B. Brando | S. Siena | F. Ravagnani | A. Gianni | M. Bregni
[1] G. Bonadonna,et al. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] G. Bonadonna,et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Blood.
[3] A. Pileri,et al. GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.
[4] G. Bonadonna,et al. Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy? , 1989, Hematological oncology.
[5] W. Piacibello,et al. Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. , 1989, The Journal of clinical investigation.
[6] I. Bernstein,et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. , 1988, The Journal of clinical investigation.
[7] B. Clarkson,et al. Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. , 1985, Blood.
[8] R. Abrams,et al. Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. , 1981, The Journal of clinical investigation.